Literature DB >> 12952184

Early events: the in vitro conversion of BMP transduced fibroblasts to chondroblasts.

R Bruce Rutherford1, Keni Gu, Pat Racenis, Paul H Krebsbach.   

Abstract

Strategies for localized skeletal regeneration using either cell or ex vivo gene transfer typically utilize preosteoblasts from bone or bone marrow biopsies. Our studies have demonstrated than ex vivo bone morphogenetic proteins (BMP) transduced fibroblasts convert to osteoblasts and form bone in vivo. In addition when suspended in a variety of thermoset hydrogels, these cells are capable of ectopic or orthotopic bone formation. To study the mechanism of the phenotypic conversion of BMP transduced fibroblasts, we have initiated characterization of three-dimensional (3D) cultures derived from these cell/collagen hydrogel composites. These data reveal that the BMP, but not control transduced fibroblasts, secrete BMP-7 and acquire some chondroblastic traits in 3D cultures. These traits include altered cell shape and changes in the extracellular matrix such as accumulation of cartilage proteoglycan, type II collagen, and mineral deposition by 3 weeks. These studies suggest that this culture system may be useful for elucidating early mechanistic events in the BMP-induced conversion of fibroblasts to osteoblasts.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12952184

Source DB:  PubMed          Journal:  Connect Tissue Res        ISSN: 0300-8207            Impact factor:   3.417


  2 in total

1.  Endogenous bone morphogenetic proteins mediate 1alpha, 25-dihydroxyvitamin D(3)-induced expression of osteoblast differentiation markers in human dermal fibroblasts.

Authors:  Christopher K Hee; Steven B Nicoll
Journal:  J Orthop Res       Date:  2009-02       Impact factor: 3.494

2.  Skin fibroblasts from patients with type 1 diabetes (T1D) can be chemically transdifferentiated into insulin-expressing clusters: a transgene-free approach.

Authors:  Federico Pereyra-Bonnet; María L Gimeno; Nelson R Argumedo; Marcelo Ielpi; Johana A Cardozo; Carla A Giménez; Sung-Ho Hyon; Marta Balzaretti; Mónica Loresi; Patricia Fainstein-Day; León E Litwak; Pablo F Argibay
Journal:  PLoS One       Date:  2014-06-25       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.